Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Nonlinear relationship between vitamin D status on admission and bronchopulmonary dysplasia in preterm infants

Abstract

Background

This research will explore non-linear relationship between vitamin D status on admission and bronchopulmonary dysplasia (BPD) in preterm infants.

Methods

Data were retrospectively collected on preterm infants ≤32 weeks gestation and ≥28 weeks gestation hospitalized in our hospital between Jan. 2019 and Jul. 2022, which were classified into BPD and non-BPD groups according to BPD diagnostic criteria. Independent influences between the two groups were staged using comparison of differences between groups, univariate analysis, multivariate analysis, smoothed curve fitting, and threshold effect staging.

Results

255 preterm infants were enrolled in this research, including 135 males and 120 females, with a mean gestational age of 30.59 ± 0.86 weeks. Vitamin D status on admission was an independent protective factor for BPD in preterm infants, with a 6% reduction in the probability of BPD for every 1 ng/ml increase in vitamin D status on admission (p = 0.036). There was also a non-linear relationship, with each 1 ng/ml increase in vitamin D status on admission being associated with an 87% reduction in the incidence of BPD when vitamin D status was <12.82 ng/ml (p = 0.010).

Conclusion

Vitamin D status on admission and BPD are non-linearly in preterm infants at 28–32 weeks gestation.

Impact statement

  • Analyzing the relationship between vitamin D status on admission and BPD.

  • A nonlinear relationship and turning point between vitamin D status on admission and BPD was derived by curve fitting and threshold effect.

  • We provide a new reference point for vitamin D supplementation for the prevention of neonatal BPD and to avoid ineffective overmedication.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are not publicly available due to human research ethics requirements but are available from the corresponding author on reasonable request.

References

  1. Northway, W. H. Jr, Rosan, R. C. & Porter, D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276, 357–368 (1967).

    Article  PubMed  Google Scholar 

  2. Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723–1729 (2001).

    Article  CAS  PubMed  Google Scholar 

  3. Stoll, B. J. et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443–456 (2010).

    Article  PubMed  Google Scholar 

  4. Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314, 1039–1051 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Horbar, J. D. et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr. 171, e164396 (2017).

    Article  PubMed  Google Scholar 

  6. Li, P. P. & Zhao, W. Definition evolution and epidemiological characteristics of bronchopulmonary dysplasia in premature infants. Chin. J. Neonatol. 35, 385–388 (2020).

    Google Scholar 

  7. Jensen, E. A. et al. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics 148, e2020030007 (2021).

    Article  PubMed  Google Scholar 

  8. Davidson, L. M. & Berkelhamer, S. K. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J. Clin. Med. 6, 4 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bhandari, A. & Panitch, H. B. Pulmonary outcomes in bronchopulmonary dysplasia. Semin. Perinatol. 30, 219–226 (2006).

    Article  PubMed  Google Scholar 

  10. Hartling, L., Liang, Y. & Lacaze-Masmonteil, T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch. Dis. Child Fetal Neonatal Ed. 97, F8–F17 (2012).

    Article  PubMed  Google Scholar 

  11. Bose, C. et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 124, e450–e458 (2009).

    Article  PubMed  Google Scholar 

  12. Leary, S., Das, P., Ponnalagu, D., Singh, H. & Bhandari, V. Genetic strain and sex differences in a hyperoxia-induced mouse model of varying severity of bronchopulmonary dysplasia. Am. J. Pathol. 189, 999–1014 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Antonucci, R., Contu, P., Porcella, A., Atzeni, C. & Chiappe, S. Intrauterine smoke exposure: a new risk factor for bronchopulmonary dysplasia? J. Perinat. Med. 32, 272–277 (2004).

    Article  PubMed  Google Scholar 

  14. Ahmad, S. et al. Vitamin D and its therapeutic relevance in pulmonary diseases. J. Nutr. Biochem. 90, 108571 (2021).

    Article  CAS  PubMed  Google Scholar 

  15. Brehm, J. M. et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am. J. Respir. Crit. Care Med. 186, 140–146 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mao, X. et al. Vitamin D and IL-10 deficiency in preterm neonates with bronchopulmonary dysplasia. Front. Pediatr. 6, 246 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ge, H. et al. The association of vitamin D and vitamin E levels at birth with bronchopulmonary dysplasia in preterm infants. Pediatr. Pulmonol. 56, 2108–2113 (2021).

    Article  PubMed  Google Scholar 

  18. Joung, K. E. et al. Vitamin D and bronchopulmonary dysplasia in preterm infants. J. Perinatol. 36, 878–882 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Tsuprykov, O. et al. Opposite correlation of 25-hydroxy-vitamin D- and 1,25-dihydroxy-vitamin D-metabolites with gestational age, bone- and lipid-biomarkers in pregnant women. Sci. Rep. 11, 1923 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Çetinkaya, M. et al. Maternal/neonatal vitamin D deficiency: a risk factor for bronchopulmonary dysplasia in preterms? J. Perinatol. 35, 813–817 (2015).

    Article  PubMed  Google Scholar 

  21. Ali, Z., Schmidt, P., Dodd, J. & Jeppesen, D. L. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children. Dan. Med. J. 60, A4688 (2013).

    PubMed  Google Scholar 

  22. Yin, J. et al. Mechanical ventilation characteristics and their prediction performance for the risk of moderate and severe bronchopulmonary dysplasia in infants with gestational age <30 weeks and birth weight <1500 g. Front. Pediatr. 10, 993167 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Park, H. W. et al. Association between vitamin D level and bronchopulmonary dysplasia: a systematic review and meta-analysis. PLoS ONE 15, e0235332 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kalikkot Thekkeveedu, R., Guaman, M. C. & Shivanna, B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir. Med. 132, 170–177 (2017).

    Article  PubMed  Google Scholar 

  25. Sakurai, R. et al. 1alpha,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L496–L505 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Hu, J. et al. Vitamin D ameliorates apoptosis and inflammation by targeting the mitochondrial and MEK1/2-ERK1/2 pathways in hyperoxia-induced bronchopulmonary dysplasia. J. Inflamm. Res. 15, 4891–4906 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mandell, E. et al. Antenatal endotoxin disrupts lung vitamin D receptor and 25-hydroxyvitamin D 1α-hydroxylase expression in the developing rat. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L1018–L1026 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Weisman, Y. Maternal, fetal and neonatal vitamin D and calcium metabolism during pregnancy and lactation. Endocr. Dev. 6, 34–49 (2003).

    Article  CAS  PubMed  Google Scholar 

  29. McCarthy, R. A. et al. Vitamin D nutritional status in preterm infants and response to supplementation. Br. J. Nutr. 110, 156–163 (2013).

    Article  CAS  PubMed  Google Scholar 

  30. Burris, H. H. et al. Vitamin D status among preterm and full-term infants at birth. Pediatr. Res. 75, 75–80 (2014).

    Article  CAS  PubMed  Google Scholar 

  31. Misra, M., Pacaud, D., Petryk, A., Collett-Solberg, P. F. & Kappy, M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122, 398–417 (2008).

    Article  PubMed  Google Scholar 

  32. Hollis, B. W., Johnson, D., Hulsey, T. C., Ebeling, M. & Wagner, C. L. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone Min. Res. 26, 2341–2357 (2011).

    Article  CAS  Google Scholar 

  33. Wagner, C. L. et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 208, 137.e1–13 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the research personnel and the research volunteers involved with the project.

Funding

This work was supported by the National Natural Science Foundation of China (81801510, 82071693) and supported by Natural Science Foundation of Hunan Province (2019JJ50930, 2021JJ31046).

Author information

Authors and Affiliations

Authors

Contributions

Shuo Wang: substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and interpretation of data; final approval of the version to be published. Mingjie Wang: substantial contributions to acquisition of data. Xiaohe Yu: substantial contributions to acquisition of data. Chuanding Cao: substantial contributions to acquisition of data. Ying Ding: substantial contributions to acquisition of data. Mei Lv: substantial contributions to acquisition of data. Yang Liu: substantial contributions to acquisition of data. Meiyan Chu: substantial contributions to acquisition of data. Keren Fang: substantial contributions to acquisition of data. Zhengchang Liao: substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and interpretation of data; final approval of the version to be published. Shaojie Yue: substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and interpretation of data; final approval of the version to be published.

Corresponding authors

Correspondence to Zhengchang Liao or Shaojie Yue.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, S., Wang, M., Yu, X. et al. Nonlinear relationship between vitamin D status on admission and bronchopulmonary dysplasia in preterm infants. Pediatr Res 97, 2074–2081 (2025). https://doi.org/10.1038/s41390-024-03621-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41390-024-03621-6

Search

Quick links